Sort by
Refine Your Search
- 
                Listed
- 
                Employer- J. Heyrovský Institute of Physical Chemistry of the CAS, v. v. i.
- MASARYK UNIVERSITY
- Charles University
- Charles University, Faculty of Pharmacy in Hradec Kralove
- Institute of Physics of the Czech Academy of Sciences
- Masaryk University - Faculty of Science – RECETOX
- UCT Prague
- University of Chemistry and Technology Prague
 
- 
                Field
- 
                
                
                the development and systematic characterization of quantum devices based on novel triple-hybrid materials, which combine superconductivity, magnetism and semiconducting properties within a single in-situ grown 
- 
                
                
                on the development of new synthetic methods in organic chemistry. Currently, we study directed C−H functionalizations of alkanes and cycloalkanes utilizing insertion reactions of electron-deficient species and C−H 
- 
                
                
                . 10.2025 Job description: We are seeking a highly motivated PhD student to join our research group at J. Heyrovský Institute of Physical Chemistry. The project focuses on developing advanced fluorescence 
- 
                
                
                the study of toxic compounds, their environmental behaviour, transport, and bioaccumulation, with the aim of assessing human health risks and developing technologies to mitigate them. About the Research 
- 
                
                
                ). The candidate should have hands-on experience developing state-of-the-art machine learning models, particularly deep neural networks (experience with graph neural networks is highly valued). Their background 
- 
                
                
                partners, coordinated by Fraunhofer ICT in Germany. The network will recruit a total of 17 doctoral candidates for project work lasting for 36 months. SPACER aims to develop new architectures for porous 
- 
                
                
                (OncoPharm), project ID CZ.02.01.01/00/23_021/0008442, within the Operation Programme Johannes Amos Commenius (OP JAK), P 1: Research and Development, SO 1.1: Developing and enhancing research and innovation 
- 
                
                
                is funded under Marie Sklodowska-Curie actions (HORIZON-MSCA-2024-DN-01-01). The successful applicant will develop a novel method enabling the estimation of the permittivity within protein channel 
- 
                
                
                hours EMBO support for further education and professional development: meeting grants, lab visiting fellowships, interview support, young investigator PhD course, Lindau Nobel Laureate meeting, bridging 
- 
                
                
                equipment and experienced staff Full-time contract An attractive salary (ERC funded position) Flexible working hours Support for further education and professional development Benefits package: 6 weeks